Targeted Therapies in Rare Brain Tumours

Rare central nervous system (CNS) tumours represent a unique challenge. Given the difficulty of conducting dedicated clinical trials, there is a lack of therapies for these tumours supported by high quality evidence, and knowledge regarding the impact of standard treatments (i.e., surgery, radiother...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruno, Francesco, Pellerino, Alessia, Bertero, Luca, Soffietti, Riccardo, Rudà, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348084/
https://www.ncbi.nlm.nih.gov/pubmed/34360713
http://dx.doi.org/10.3390/ijms22157949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348084/
https://www.ncbi.nlm.nih.gov/pubmed/34360713
http://dx.doi.org/10.3390/ijms22157949

Ejemplares similares